SARS-CoV-2 RNA, strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429
nucleic-acid

SARS-CoV-2 RNA, strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429

EVAg
Produced by
: RIVM
Shipping From
: Bilthoven - NL

Product Description

Ref-SKU:
014N-04146
RNA extracted from infected cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Aruba_11401/2021, California variant, nextstrain clade CAL.20C, lineage B.1.429).
Product Risk Group: 
RG1

Information on the related virus

ICTV Taxonomy: 
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus / Sarbecovirus / Severe acute respiratory syndrome-related coronavirus
Virus name: 
SARS-CoV-2
Strain: 
strain hCoV-19/Aruba_11401/2021
Variant: 
20C/452R (B.1.427/ B.1.429)


Unit definition: 
1 vial containing 250 µl

In stock

550,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Cloned Product: No
Can it be used to produce GMO: 
No
Sequencing: 
Fully sequenced
Sequence checked: 
Yes
Mutations: 
No mutation compared to the reference sequence
Nucleic Acid preparation technique: 
Roche, MagNA Pure, elution in 50 µl TE buffer, subsequently dilution in nuclease-free water
Titer: 
E gene: 6.24*10^6 cps/250 µl ; RdRP gene: 6.56*10^6 cps/250 µl (updated 9-6-21, 19:18)
Storage conditions: 
Nuclease-Free Water -80C
Shipping conditions: 
Dry ice
IATA Classification: 
NON DANGEROUS GOODS
Virus host type: 
Human virus
Previous Name or Taxonomy: 
2019-nCoV
nCoV-2019

Information about the origin of the product

Biological material origin: 
Natural origin
Collection date: 
Sunday, 21 February, 2021
Country of collection: 
Aruba